Placeholder

Ibrutinib Manufacturer

Active IngredientIbrutinib
Dosage FormCapsules
Available Strength140mg
Packaging30 capsules in 1 bottle
Therapeutic useMantle-cell lymphoma, Blood cancer (Chronic lymphocytic leukemia)
Pack Insert/LeafletYes
Production Capacity1 Million Bottle's/Month

Description

Reviews

There are no reviews yet.

Be the first to review “Ibrutinib Manufacturer”

Your email address will not be published. Required fields are marked *